Võrdle meetodeid

	DEXA	Radiomics
Valdkond	Meditsiiniline piltdiagnostika	Meditsiiniline piltdiagnostika
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	1987	2012
Looja	Harold Wahner	Philippe Lambin
Tüüp	X-ray-based bone density measurement	Machine learning-based texture and morphology analysis
Algallikas	Kanis, J. A. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series, 843, 1-129.	Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. (2012). Radiomics: extracting more information from medical images using advanced feature analysis. Nature Reviews Clinical Oncology, 9(12), 676-684.
Rööpnimetused	Dual X-ray absorptiometry, DXA, bone densitometry	texture analysis, radiomics analysis, quantitative imaging biomarkers
Seotud	5	5
Kokkuvõte	Dual-Energy X-ray Absorptiometry (DEXA or DXA) is a non-invasive imaging technique that quantifies bone mineral density (BMD) by measuring the attenuation of X-rays at two different energies as they pass through bone and soft tissue. First developed by Wahner and colleagues in 1987, DEXA has become the gold standard for osteoporosis screening and fracture risk assessment. It is recommended by the World Health Organization for diagnosing osteoporosis and monitoring treatment response.	Radiomics is a computational methodology that extracts large numbers of quantitative features from medical images (CT, MRI, PET) using automated image analysis and machine learning to discover imaging biomarkers associated with disease phenotype, prognosis, and treatment response. Developed by Lambin, Gillies, and colleagues in 2012, radiomics aims to decode the biology underlying visible imaging patterns, enabling personalized medicine through image-based phenotyping. It has emerged as a powerful tool in oncology for tumor characterization, prognosis prediction, and therapy response assessment.